Cargando…

Xenogeneic materials for the surgical treatment of aortic infections

BACKGROUND: The surgical treatment of aortic infections (AIs) is challenging. In situ aortic reconstructions represent nowadays the favored therapy for fit patients and xenogeneic materials are used increasingly. The aim of this study was to present our experience with xenogeneic reconstructions for...

Descripción completa

Detalles Bibliográficos
Autores principales: Keschenau, Paula R., Gombert, Alexander, Barbati, Mohammed E., Jalaie, Houman, Kalder, Johannes, Jacobs, Michael J., Kotelis, Drosos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182519/
https://www.ncbi.nlm.nih.gov/pubmed/34164193
http://dx.doi.org/10.21037/jtd-20-3481
_version_ 1783704223248023552
author Keschenau, Paula R.
Gombert, Alexander
Barbati, Mohammed E.
Jalaie, Houman
Kalder, Johannes
Jacobs, Michael J.
Kotelis, Drosos
author_facet Keschenau, Paula R.
Gombert, Alexander
Barbati, Mohammed E.
Jalaie, Houman
Kalder, Johannes
Jacobs, Michael J.
Kotelis, Drosos
author_sort Keschenau, Paula R.
collection PubMed
description BACKGROUND: The surgical treatment of aortic infections (AIs) is challenging. In situ aortic reconstructions represent nowadays the favored therapy for fit patients and xenogeneic materials are used increasingly. The aim of this study was to present our experience with xenogeneic reconstructions for AI using self-made bovine pericardium tubes and/or the biosynthetic Omniflow(®) II graft. METHODS: This retrospective single-center study included all patients undergoing xenogeneic aortic and aortoiliac reconstructions from December 2015 to June 2020. Patient comorbidities, symptoms, procedural characteristics, types of pathogens and postoperative outcomes were analyzed. RESULTS: Twenty-eight patients [23 male (82%), median age 68 (range, 28–84) years] were included. Ten patients (36%) had native AIs and 18 (64%) had graft infections, including 3 (11%) aortoesophageal and 2 (7%) aortoduodenal fistulas (ADF). Twenty-four patients (86%) were symptomatic, the most common symptoms being contained aortic rupture (n=8) and sepsis (n=4). The surgical procedures were infra- and juxtarenal aortic repairs (n=11, 39% and n=7, 25%), thoracoabdominal aortic repairs (type IV: n=1, 4%; type V: n=3, 11%), descending thoracic aortic repairs (n=4, 14%) and 2 reconstructions (7%) involving the ascending aorta/aortic arch. Most were urgent (n=10, 43%) or emergent operations (n=11, 35%). Identification of pathogen(s), mostly Gram-positive bacteria, was possible in 25 patients (89%). Twelve patients (43%) had polymicrobial infections and 6 (21%) infections with multi-resistant bacteria. In-hospital mortality was 32% (n=9) due to acute cardiac failure (1/9), endocarditis (1/9), bleeding (3/9) and sepsis (4/9). The most frequent complications were transient need for dialysis (n=12, 43%) and persisting sepsis (n=11, 39%). Two early occlusions of Omniflow(®) II grafts were observed (7%). Median follow-up (FU), during which 2 patients died of non-aortic causes, was 14 months (95% CI: 9–19 months). Freedom from reoperation was 100%, there was no evidence for reinfection during FU. CONCLUSIONS: Xenogeneic orthotopic reconstructions for AI can be performed at all aortic levels. Combining bovine pericardium and the Omniflow(®) II graft can be useful for reconstructing the branched aortic segments and both materials show appropriate early to midterm outcomes. Nonetheless, AIs are serious conditions associated with relevant morbidity/mortality rates, even in a specialized center.
format Online
Article
Text
id pubmed-8182519
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-81825192021-06-22 Xenogeneic materials for the surgical treatment of aortic infections Keschenau, Paula R. Gombert, Alexander Barbati, Mohammed E. Jalaie, Houman Kalder, Johannes Jacobs, Michael J. Kotelis, Drosos J Thorac Dis Original Article BACKGROUND: The surgical treatment of aortic infections (AIs) is challenging. In situ aortic reconstructions represent nowadays the favored therapy for fit patients and xenogeneic materials are used increasingly. The aim of this study was to present our experience with xenogeneic reconstructions for AI using self-made bovine pericardium tubes and/or the biosynthetic Omniflow(®) II graft. METHODS: This retrospective single-center study included all patients undergoing xenogeneic aortic and aortoiliac reconstructions from December 2015 to June 2020. Patient comorbidities, symptoms, procedural characteristics, types of pathogens and postoperative outcomes were analyzed. RESULTS: Twenty-eight patients [23 male (82%), median age 68 (range, 28–84) years] were included. Ten patients (36%) had native AIs and 18 (64%) had graft infections, including 3 (11%) aortoesophageal and 2 (7%) aortoduodenal fistulas (ADF). Twenty-four patients (86%) were symptomatic, the most common symptoms being contained aortic rupture (n=8) and sepsis (n=4). The surgical procedures were infra- and juxtarenal aortic repairs (n=11, 39% and n=7, 25%), thoracoabdominal aortic repairs (type IV: n=1, 4%; type V: n=3, 11%), descending thoracic aortic repairs (n=4, 14%) and 2 reconstructions (7%) involving the ascending aorta/aortic arch. Most were urgent (n=10, 43%) or emergent operations (n=11, 35%). Identification of pathogen(s), mostly Gram-positive bacteria, was possible in 25 patients (89%). Twelve patients (43%) had polymicrobial infections and 6 (21%) infections with multi-resistant bacteria. In-hospital mortality was 32% (n=9) due to acute cardiac failure (1/9), endocarditis (1/9), bleeding (3/9) and sepsis (4/9). The most frequent complications were transient need for dialysis (n=12, 43%) and persisting sepsis (n=11, 39%). Two early occlusions of Omniflow(®) II grafts were observed (7%). Median follow-up (FU), during which 2 patients died of non-aortic causes, was 14 months (95% CI: 9–19 months). Freedom from reoperation was 100%, there was no evidence for reinfection during FU. CONCLUSIONS: Xenogeneic orthotopic reconstructions for AI can be performed at all aortic levels. Combining bovine pericardium and the Omniflow(®) II graft can be useful for reconstructing the branched aortic segments and both materials show appropriate early to midterm outcomes. Nonetheless, AIs are serious conditions associated with relevant morbidity/mortality rates, even in a specialized center. AME Publishing Company 2021-05 /pmc/articles/PMC8182519/ /pubmed/34164193 http://dx.doi.org/10.21037/jtd-20-3481 Text en 2021 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Keschenau, Paula R.
Gombert, Alexander
Barbati, Mohammed E.
Jalaie, Houman
Kalder, Johannes
Jacobs, Michael J.
Kotelis, Drosos
Xenogeneic materials for the surgical treatment of aortic infections
title Xenogeneic materials for the surgical treatment of aortic infections
title_full Xenogeneic materials for the surgical treatment of aortic infections
title_fullStr Xenogeneic materials for the surgical treatment of aortic infections
title_full_unstemmed Xenogeneic materials for the surgical treatment of aortic infections
title_short Xenogeneic materials for the surgical treatment of aortic infections
title_sort xenogeneic materials for the surgical treatment of aortic infections
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182519/
https://www.ncbi.nlm.nih.gov/pubmed/34164193
http://dx.doi.org/10.21037/jtd-20-3481
work_keys_str_mv AT keschenaupaular xenogeneicmaterialsforthesurgicaltreatmentofaorticinfections
AT gombertalexander xenogeneicmaterialsforthesurgicaltreatmentofaorticinfections
AT barbatimohammede xenogeneicmaterialsforthesurgicaltreatmentofaorticinfections
AT jalaiehouman xenogeneicmaterialsforthesurgicaltreatmentofaorticinfections
AT kalderjohannes xenogeneicmaterialsforthesurgicaltreatmentofaorticinfections
AT jacobsmichaelj xenogeneicmaterialsforthesurgicaltreatmentofaorticinfections
AT kotelisdrosos xenogeneicmaterialsforthesurgicaltreatmentofaorticinfections